Rapid reversal of anticoagulant bleeding- rFVIIa an option?

Rapid reversal of anticoagulant bleeding- rFVIIa an option?

Bibliographic Details
Main Author:	Zupancic-Salek Silva
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2007-01-01
Series:	Journal of Postgraduate Medicine
Online Access:	http://www.jpgmonline.com/article.asp?issn=0022-3859;year=2007;volume=53;issue=1;spage=3;epage=4;aulast=Zupancic-Salek

Similar Items

Bioengineering of rFVIIa Biopharmaceutical and Structure Characterization for Biosimilarity Assessment
by: Othman Montacir, et al.
Published: (2018-01-01)

Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients
by: Heng Joo Ng, et al.
Published: (2006-12-01)

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
by: Aggarwal Anita, et al.
Published: (2004-11-01)

Inhaled recombinant activated factor VII (rFVIIa) in the management of blast lung injury
by: Smith, Jason Edward
Published: (2012)

Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy
by: Dario Nicosia, et al.
Published: (2019-04-01)

Impacto da utilização do rFVIIa nas hemorragias intracranianas: Revisão da literatura
by: Daniel Damiani, et al.
Published: (2009-09-01)

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia
by: Man-Chiu Poon
Published: (2007-11-01)

Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia A with Inhibitors: Current Perspectives and Emerging Clinical Evidence
by: Linari S, et al.
Published: (2020-05-01)

Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury
by: Bobby Kim, et al.
Published: (2014-01-01)

Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use
by: Charlotte Bomken, et al.
Published: (2009-01-01)

Local pulmonary administration of factor VIIa (rFVIIa) in diffuse alveolar hemorrhage (DAH) &ndash; a review of a new treatment paradigm
by: Nielsen JD, et al.
Published: (2012-03-01)

Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC)
by: Rajpurkar M, et al.
Published: (2019-09-01)

Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016
by: Steve Christos, et al.
Published: (2016-05-01)

Anticoagulants and Gastrointestinal Bleeding
by: Mark Crowther, et al.
Published: (2005-01-01)

This Article Corrects: “Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016”
by: Steve Christos, et al.
Published: (2016-09-01)

The practical management of bleedings during treatment with direct oral anticoagulants: the emergency reversal therapy
by: Luca Masotti, et al.
Published: (2013-12-01)

Characterization of a novel EPHB2 R155C mutant with respect to its proteolytic cleavage by TF/FVIIa
by: Akcan, Ece
Published: (2021)

Understanding Bleeding Risk after Anticoagulation.
Published: (2005-10-01)

Bleeding issues in women prescribed anticoagulation
by: V. Speed, et al.
Published: (2021-12-01)

Adipocytes express tissue factor and FVII and are procoagulant in a TF/FVIIa-dependent manner
by: Desirée Edén, et al.
Published: (2019-07-01)

Determination of FVIIa-sTF Inhibitors in Toxic Microcystis Cyanobacteria by LC-MS Technique
by: Andrea Roxanne J. Anas, et al.
Published: (2015-12-01)

Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
by: Bethany Samuelson Bannow, et al.
Published: (2021-07-01)

Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells
by: Alvarado Carlos S, et al.
Published: (2008-03-01)

Emergency Reversal of Anticoagulation
by: Jennifer Yee, et al.
Published: (2019-07-01)

Prothrombin Complex Concentrate for Rapid Reversal of Warfarin Anticoagulation to Allow Neuraxial Blockade
by: Conor Skerritt, et al.
Published: (2014-01-01)

Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.
by: Genmin Lu, et al.
Published: (2018-01-01)

Percutaneous closure of the left atrial appendage with Watchman device: An option for patients with atrial fibrilation and high risk of bleeding with anticoagulation
by: Sénior, Juan, et al.
Published: (2015-07-01)

TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity
by: Stavik Benedicte, et al.
Published: (2013-01-01)

FVIIa-sTF and Thrombin Inhibitory Activities of Compounds Isolated from Microcystis aeruginosa K-139
by: Andrea Roxanne J. Anas, et al.
Published: (2017-08-01)

MINIMISATION OF BLEEDING RISKS DUE TO DIRECT ORAL ANTICOAGULANTS
by: Ovidiu Vornicu, et al.
Published: (2016-07-01)

Evaluation of bleeding in patients receiving direct oral anticoagulants
by: Hellenbart EL, et al.
Published: (2017-08-01)

Microbleed prevalence and burden in anticoagulant‐associated intracerebral bleed
by: Vasileios‐Arsenios Lioutas, et al.
Published: (2019-08-01)

Impact of INR monitoring, reversal agent use, heparin bridging, and anticoagulant interruption on rebleeding and thromboembolism in acute gastrointestinal bleeding.
by: Naoyoshi Nagata, et al.
Published: (2017-01-01)

Managing a Rivaroxaban Bleed: Understanding the Difficulties in Acute Reversal of the New Oral Anticoagulants through a Case Report
by: Naveen Nannapaneni, et al.
Published: (2014-01-01)

Reversal of direct oral anticoagulants
by: Almegren M
Published: (2017-07-01)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
by: Ramón Lecumberri, et al.
Published: (2021-07-01)

Crystal structure, epitope, and functional impact of an antibody against a superactive FVIIa provide insights into allosteric mechanism
by: Longguang Jiang, et al.
Published: (2019-07-01)

Variceal bleeding: Management options
by: Al Mofleh Ibrahim, et al.
Published: (1995-01-01)

Clinical protocols for oral anticoagulant reversal during high risk of bleeding for emergency surgical and nonsurgical settings: a narrative review
by: Carlos Galhardo, Jr., et al.
Published: (2021-07-01)

Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran
by: Giannandrea D, et al.
Published: (2019-05-01)